{"id":58,"date":"2025-08-22T12:47:04","date_gmt":"2025-08-22T12:47:04","guid":{"rendered":"https:\/\/qloudtechnologies.com\/blog\/?p=58"},"modified":"2025-08-22T12:47:05","modified_gmt":"2025-08-22T12:47:05","slug":"arthur-hayes-pardoned-by-trump-from-crypto-trading-to-stem-cell-biohacking","status":"publish","type":"post","link":"https:\/\/qloudtechnologies.com\/blog\/arthur-hayes-pardoned-by-trump-from-crypto-trading-to-stem-cell-biohacking\/","title":{"rendered":"Arthur Hayes Pardoned by Trump: From Crypto Trading to Stem Cell Biohacking"},"content":{"rendered":"\n

Once the rebel of crypto derivatives, Arthur Hayes is now betting big on biohacking \u2014 shifting his energy from financial disruption to the science of longevity.<\/em><\/p>\n\n\n\n

Trump\u2019s Pardon and Hayes\u2019 Reinvention<\/strong><\/h2>\n\n\n\n

Arthur Hayes, the co-founder of BitMEX, is no stranger to controversy. He made billions pioneering crypto derivatives trading, only to face indictment in 2020 for violating the Bank Secrecy Act. By 2022, Hayes and fellow BitMEX founders Benjamin Delo and Samuel Reed pleaded guilty, each paying $10 million in fines and serving probation.<\/p>\n\n\n\n

In March 2025, President Donald Trump granted pardons to the trio, wiping the slate clean. While the legal drama grabbed headlines, Hayes\u2019 next chapter may prove even more disruptive.<\/p>\n\n\n\n

From Crypto Gains to Stem Cell Clinics<\/strong><\/h2>\n\n\n\n

Instead of returning solely to crypto markets, Hayes is channeling his wealth into biotech \u2014 specifically, stem cell treatments and biohacking<\/strong>.<\/p>\n\n\n\n

For over a year, Hayes has been a patient at clinics in Mexico and Bangkok, receiving stem cell infusions designed to extend healthspan. Recently, he took a major stake in one of the companies behind these treatments, joining its board during a rebrand.<\/p>\n\n\n\n

\u201cI want to live as long as possible, as healthy as possible,\u201d Hayes said in a video interview. \u201cThis is the future \u2014 you\u2019re seeing more and more countries relaxing their regulations around the use of stem cells.\u201d<\/p>\n\n\n\n

It\u2019s a bold pivot: from disrupting financial markets to disrupting human biology.<\/p>\n\n\n\n

Longevity: Crypto\u2019s New Obsession<\/strong><\/h2>\n\n\n\n

Hayes is part of a growing trend among crypto elites who view longevity as the final frontier<\/strong>:<\/p>\n\n\n\n

    \n
  • Vitalik Buterin (Ethereum co-founder)<\/strong>\u00a0\u2192 Donated millions to life-extension research.<\/li>\n\n\n\n
  • Brian Armstrong (Coinbase CEO)<\/strong>\u00a0\u2192 Co-founded\u00a0NewLimit<\/strong>, a genetic engineering startup that raised $130M in Series B funding.<\/li>\n\n\n\n
  • Balaji Srinivasan (ex-Coinbase CTO)<\/strong>\u00a0\u2192 Invested in biotech and alternative societies.<\/li>\n<\/ul>\n\n\n\n

    For these founders, crypto wealth provides freedom to experiment where traditional institutions move slowly \u2014 whether in genetics, biotech, or radical health optimization.<\/p>\n\n\n\n

    The Treasury Boom and Trump\u2019s Digital Footprint<\/strong><\/h2>\n\n\n\n

    Hayes hasn\u2019t left crypto behind. Through his family office, Maelstrom, he has invested in Digital Asset Treasury (DAT) firms<\/strong> \u2014 public companies that accumulate Bitcoin and other tokens on their balance sheets.<\/p>\n\n\n\n

    DATs have surged in popularity, holding more than $110 billion worth of Bitcoin according to CoinGecko. But Hayes warns the rush may overshoot: if these treasuries can\u2019t achieve scale and attract institutional index funds, many could face sharp discounts.<\/p>\n\n\n\n

    Even Trump has embraced the model:<\/p>\n\n\n\n

      \n
    • Trump Media<\/strong>\u00a0raised over $2B this year to buy Bitcoin.<\/li>\n\n\n\n
    • Alt5 Sigma Corp.<\/strong>, linked to Trump allies, announced plans to raise $1.5B for crypto.<\/li>\n\n\n\n
    • Trump\u2019s sons have entered crypto mining.<\/li>\n\n\n\n
    • Trump and Melania even launched their own memecoins, though prices have since collapsed by ~80%.<\/li>\n<\/ul>\n\n\n\n

      For Hayes, this isn\u2019t a red flag \u2014 it\u2019s validation. \u201cIf you have the president of the empire creating his own memecoin and it\u2019s freely tradable, that gives license to other politicians to use memecoins as campaign finance,\u201d he noted.<\/p>\n\n\n\n

      AI Satoshi\u2019s Analysis<\/strong><\/h2>\n\n\n\n
      \n

      This move illustrates how crypto pioneers, once focused on disrupting finance, are now redirecting capital toward biotech and life-extension, industries they view as over-regulated yet ripe for transformation. The pattern mirrors Bitcoin\u2019s ethos \u2014 challenging entrenched systems with alternative models built on conviction and capital. Hayes\u2019s pivot highlights how financial independence from crypto enables, experimentation beyond monetary systems, potentially accelerating innovation where legacy institutions hesitate.<\/p>\n<\/blockquote>\n\n\n\n

      \n